Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100

Labcorp Holdings Inc. (LH) Free cash flow

Alert me on Free cash flow

Labcorp Holdings Inc.'s free cash flow for fiscal 2025 was $1.2B, up 10.6% from $1.1B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.2B. Over the past ten years it has ranged from $727.2M (fiscal 2015) to $2.8B (fiscal 2021); the current reading is higher than 73% of that period. Labcorp Holdings Inc. ranks 7th of 52 Diagnostics & Research companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $1.2B 10.57%
FY2024 $1.1B 25.52%
FY2023 $874.7M (42.76%)
FY2022 $1.5B (44.94%)
FY2021 $2.8B 54.56%
FY2020 $1.8B 70.66%
FY2019 $1.1B 7.84%
FY2018 $975.7M (17.88%)
FY2017 $1.2B 25.21%
FY2016 $949.0M 30.50%

Quarterly newest first

Period Free cash flow Change
Jun 2026 $315.8M 303.32%
Mar 2026 $78.3M (84.18%)
Dec 2025 $494.8M 75.71%
Sep 2025 $281.6M (48.29%)
42 more quarters

Against its own ten years

Low $727.2M High $2.8B
Ten-year median $1.1B
Current reading's percentile 73

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on LH